Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized vs IV Ketamine for Post-Spinal Shivering
NCT07055828Active, not recruiting
- Sponsor
- Tanta University
- Start
- May 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in postanesthetic shivering (PAS) (3 arms), sponsored by Tanta University. Primary endpoint: Effectiveness of Nebulized Ketamine on Post-Anesthesia Shivering (PAS) Incidence and Severity at 56 days. Started May 2025; status: active, not recruiting.
02
Drugs
ketamine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on NCT07055828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07055828.